| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD24 molecule | 0.472 | 0.769 |
|
group | 0.100 | None | 1.000 | 4 | 0 | 2006 | 2018 | |||||||||
|
DIRAS family GTPase 3 | 0.631 | 0.385 |
|
group | 0.050 | None | 1.000 | 3 | 0 | 2002 | 2011 | |||||||||
|
placenta enriched 1 | 0.716 | 0.308 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
cancer/testis antigen 1B | 0.507 | 0.731 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 1998 | 2018 | |||||||||
|
PRSS3 pseudogene 2 | 0.805 | 0.385 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
fragile site, aphidicolin type, common, fra(6)(q26) | 0.792 | 0.231 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | |||||||||
|
H19 imprinted maternally expressed transcript | 0.494 | 0.923 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 1996 | 2017 | |||||||||
|
BPI fold containing family A member 4, pseudogene | 0.711 | 0.654 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
breast cancer anti-estrogen resistance 4 | 0.653 | 0.346 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2006 | 2011 | |||||||||
|
microRNA 10b | 0.509 | 0.808 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2007 | 2019 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2009 | 2019 | |||||||||
|
microRNA 17 | 0.459 | 0.846 |
|
group | 0.030 | None | 1.000 | 1 | 0 | 2006 | 2017 | |||||||||
|
microRNA 206 | 0.477 | 0.846 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2008 | 2017 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.090 | None | 1.000 | 1 | 0 | 2008 | 2016 | |||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2008 | 2016 | |||||||||
|
microRNA 222 | 0.486 | 0.808 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 2008 | 2014 | |||||||||
|
immunoglobulin kappa locus | 0.647 | 0.462 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
microRNA 146b | 0.496 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
breast cancer 3 | 0.705 | 0.269 |
|
group | 0.050 | None | 1.000 | 1 | 0 | 2002 | 2015 | |||||||||
|
brain cytoplasmic RNA 1 | 0.666 | 0.423 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2016 | |||||||||
|
annexin A8 | 0.705 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
Breast cancer, 11;22 translocation associated |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||||
|
RAB6C, member RAS oncogene family | 0.931 | 0.077 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
deleted in malignant brain tumors 1 | 0.533 | 0.654 | 4.5E-63 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2007 |